Laxmi Organic Industries (LXCHEM) Q1 25/26 earnings summary

Executive summary

• Q1 FY26 saw an 8% volume growth but a 4% revenue decline year-over-year, with Essentials up 4% (11% volume growth) and Specialities down 18% due to a product phase-out and deferred deliveries; lower acetic acid prices also impacted results.

• Essentials segment maintained stable demand in printing, packaging, and pharma, while agro and coatings markets remained weak, especially in North America and Europe.

• Specialities faced a 9% sales impact from an agrochemical product phase-out and a 4% impact from deferred deliveries, with recovery expected in H2 FY26 and offsetting products planned by Q4.

• Major CapEx projects at Dahej and Lote are on track, with Dahej mechanical completion expected by Q3/Q4 FY26 and ramp-up in FY27; Lote fluorination products ramping up, targeting 40-60% of peak revenues in FY26.

• End-to-end digitization of supply chain operations began in Q1, incurring a one-time expense of INR 79 million, aimed at improving efficiency and cost control.

Financial highlights

• Q1FY26 consolidated revenue was INR 6,929.30 million, down 4% year-over-year; volumes grew 8%.

• Essentials revenue grew 4% to INR 4,858 million (11% volume growth), offset by a 7% price decline due to lower acetic acid prices; Specialities revenue declined 18% to INR 2,071 million.

• PAT for Q1 was INR 213.91 million (3.1% margin), down from 4.8% last year.

• Adjusted EBITDA margin: Essentials at 2%, Specialities at 16%; consolidated adjusted EBITDA margin at 5.6%.

• Basic EPS for Q1FY26 was 0.77, compared to 1.24 in Q1FY25.

Outlook and guidance

• Q2 performance expected to be in line with or better than Q1; Specialities segment to recover in H2 FY26 as deferred deliveries are realized and new products offset phased-out sales.

• On track to double consolidated revenue and triple EBITDA by FY28, targeting 20% RoCE; both segments expected to double revenue by FY28.

• Dahej CapEx to drive significant growth from FY27 onward; current CapEx focus is on mechanical completion and approvals.

• Essentials volume growth to continue, with new CapEx increasing capacity.